Nantong Jinghua Pharmaceutical Co Ltd (002349) — Financial Flexibility Index
Nantong Jinghua Pharmaceutical Co Ltd (002349) has a Financial Flexibility Index of 0.26x as of September 2025. Free cash flow of CN¥102.55 Million (operating CF CN¥97.93 Million minus capex CN¥4.62 Million) represents 0% of total liabilities (CN¥393.50 Million). Check Nantong Jinghua Pharmaceutical Co Ltd (002349) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Nantong Jinghua Pharmaceutical Co Ltd Financial Flexibility Index (2006–2025)
Historical Financial Flexibility Index trend for Nantong Jinghua Pharmaceutical Co Ltd across 20 annual periods. See Nantong Jinghua Pharmaceutical Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Nantong Jinghua Pharmaceutical Co Ltd (2006–2025)
Year-by-year free cash flow to debt coverage for Nantong Jinghua Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 002349 stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.86x | CN¥361.19 Million | CN¥340.87 Million | CN¥421.13 Million | ▼ -13.6% |
| 2024 | 0.99x | CN¥341.94 Million | CN¥311.02 Million | CN¥344.66 Million | ▲ +18.2% |
| 2023 | 0.84x | CN¥319.69 Million | CN¥291.31 Million | CN¥380.75 Million | ▼ -16.4% |
| 2022 | 1.00x | CN¥419.98 Million | CN¥358.39 Million | CN¥417.93 Million | ▲ +63.6% |
| 2021 | 0.61x | CN¥386.12 Million | CN¥305.57 Million | CN¥628.54 Million | ▼ -8.0% |
| 2020 | 0.67x | CN¥446.68 Million | CN¥328.22 Million | CN¥669.29 Million | ▼ -2.0% |
| 2019 | 0.68x | CN¥540.73 Million | CN¥285.38 Million | CN¥793.62 Million | ▲ +97.2% |
| 2018 | 0.35x | CN¥243.68 Million | CN¥83.43 Million | CN¥705.27 Million | ▼ -60.3% |
| 2017 | 0.87x | CN¥517.10 Million | CN¥75.92 Million | CN¥594.47 Million | ▼ -66.3% |
| 2016 | 2.58x | CN¥588.90 Million | CN¥343.80 Million | CN¥227.87 Million | ▲ +4193.1% |
| 2015 | -0.06x | CN¥-17.19 Million | CN¥-76.01 Million | CN¥272.27 Million | ▼ -129.8% |
| 2014 | 0.21x | CN¥74.54 Million | CN¥45.70 Million | CN¥351.96 Million | ▲ +2499.7% |
| 2013 | 0.01x | CN¥2.68 Million | CN¥-54.94 Million | CN¥328.99 Million | ▼ -99.3% |
| 2012 | 1.10x | CN¥267.51 Million | CN¥77.25 Million | CN¥242.84 Million | ▲ +11.6% |
| 2011 | 0.99x | CN¥142.33 Million | CN¥41.45 Million | CN¥144.23 Million | ▼ -14.1% |
| 2010 | 1.15x | CN¥76.95 Million | CN¥41.06 Million | CN¥66.96 Million | ▲ +53.9% |
| 2009 | 0.75x | CN¥62.16 Million | CN¥57.76 Million | CN¥83.26 Million | ▲ +196.1% |
| 2008 | 0.25x | CN¥19.49 Million | CN¥17.13 Million | CN¥77.29 Million | ▼ -28.7% |
| 2007 | 0.35x | CN¥38.31 Million | CN¥33.86 Million | CN¥108.25 Million | ▲ +80.5% |
| 2006 | 0.20x | CN¥25.13 Million | CN¥22.18 Million | CN¥128.18 Million | — |